The SentiAR technology is considered a class 2 medical device, more complex than sunglasses (class 1 device) and less complex than a pacemaker (class 3). It requires approval by the FDA, and the Silva’s were able to get a $2.2 million grant from the National Institutes of Health and another $2 million from Venture Fund in St. Louis to go through the approval process. After two years in summer 2019, physicians were testing the SentiAR system in the lab for the first time…
